1-(Cyclohex-1-en-1-yl)-8-[5-(difluoromethyl)pyridin-3-yl][1,2,4]triazolo[4,3-a]quinoxaline

ID: ALA4875626

PubChem CID: 164626798

Max Phase: Preclinical

Molecular Formula: C21H17F2N5

Molecular Weight: 377.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  FC(F)c1cncc(-c2ccc3ncc4nnc(C5=CCCCC5)n4c3c2)c1

Standard InChI:  InChI=1S/C21H17F2N5/c22-20(23)16-8-15(10-24-11-16)14-6-7-17-18(9-14)28-19(12-25-17)26-27-21(28)13-4-2-1-3-5-13/h4,6-12,20H,1-3,5H2

Standard InChI Key:  LQCFRUUPBAMHIY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   34.4155  -19.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4144  -20.5146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1266  -20.9277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1248  -19.2821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8375  -19.6874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8383  -20.5105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5510  -20.9217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2633  -20.5068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5454  -19.2771    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2576  -19.6776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8572  -19.1238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.5198  -18.3836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.7075  -18.4759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1511  -17.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4030  -17.0885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8505  -16.4832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0474  -16.6562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7996  -17.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3509  -18.0510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7057  -19.2827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7068  -18.4603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9957  -18.0478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2871  -18.4608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2900  -19.2863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9975  -19.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9949  -17.2306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7022  -16.8213    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.2868  -16.8227    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8 10  1  0
  9  5  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 14 15  1  0
 14 19  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 13 14  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  1 20  1  0
 22 26  1  0
 26 27  1  0
 26 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4875626

    ---

Associated Targets(Human)

PRKDC Tchem DNA-dependent protein kinase (1929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATR Tchem ATR/ATRIP (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATM Tchem Serine-protein kinase ATM (4198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SERPINA2 Tchem Putative alpha-1-antitrypsin-related protein (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.40Molecular Weight (Monoisotopic): 377.1452AlogP: 5.23#Rotatable Bonds: 3
Polar Surface Area: 55.97Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.01CX LogP: 3.03CX LogD: 3.03
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.49Np Likeness Score: -1.21

References

1. Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G..  (2021)  BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.,  64  (17.0): [PMID:34428039] [10.1021/acs.jmedchem.1c00762]

Source